What occupational medicine advisory work is most commonly underlogged?

The most systematically underlogged categories in occupational medicine consultant retainers are: OSHA medical surveillance schedule design and BLL trigger analysis (designing the surveillance schedule for each OSHA-regulated substance — lead, hexavalent chromium, cadmium, asbestos, noise — identifying which employees require surveillance based on exposure monitoring data, and determining when BLL results trigger the medical removal protection, temporary medical removal, and return criteria under 29 CFR 1910.1025(j)(3) through (j)(4) takes 3 to 8 hours per program review and produces no visible output until a written surveillance protocol or BLL trigger analysis memo is issued); respiratory protection PLHCP advisory (reviewing the physician or licensed health care professional's questionnaire responses and spirometry results for completeness and appropriateness under 29 CFR 1910.134(e), advising on when pulmonary function test results require medical evaluation before respirator use clearance, and tracking follow-up spirometry schedules takes 2 to 5 hours per program review and is invisible until a written PLHCP advisory memo is issued); audiometric STS follow-up tracking (identifying standard threshold shifts in annual audiograms under 29 CFR 1910.95(g)(8) — a 10 dB or greater average shift from baseline at 2000, 3000, and 4000 Hz — and tracking the required follow-up audiogram, clinical referral, and OSHA 300 log recordability determination takes 1 to 3 hours per affected employee and is invisible until the STS determination and follow-up record is issued); and DOT MRO file management advisory (reviewing the employer's MRO files for completeness of custody and control form documentation, cancelled test procedures, and shy bladder evaluation documentation takes 4 to 8 hours per compliance audit and is invisible until the written advisory memo is issued).

What are typical retainer rates for occupational medicine consultants?

Retainer rates for occupational medicine consultants vary by credential level, MRO certification, and engagement scope. Occupational health nurses and physician assistants with occupational health specialty training — typically conducting medical surveillance record review, surveillance schedule tracking, and audiometric STS follow-up administrative coordination — typically bill at $85 to $140 per hour. Physicians board-certified in occupational and environmental medicine providing direct OSHA medical surveillance advisory, respiratory protection PLHCP services, and fitness-for-duty evaluation protocol development typically bill at $175 to $275 per hour. Certified Medical Review Officers (MROs) providing DOT drug and alcohol testing MRO verification and program compliance advisory typically bill at $150 to $250 per hour for program advisory (not including per-test MRO review fees, which are typically $20 to $50 per test result reviewed). FMCSA-certified medical examiners on the National Registry of Certified Medical Examiners (NRCME) providing commercial driver physical qualification advisory typically bill at $175 to $300 per hour for advisory work (separate from per-examination fees for actual DOT physicals, which typically range from $100 to $200 per examination). Monthly retainer amounts typically range from $2,500 to $8,000 per month depending on the number of employees under OSHA medical surveillance, the number of DOT-regulated employees requiring MRO advisory, and whether the retainer covers actual MRO test result verification, FMCSA driver qualification tracking, and fitness-for-duty protocol development or only advisory and compliance review services.

Blog › ICP guides

Occupational medicine consultant on retainer: OSHA medical surveillance advisory, DOT drug and alcohol testing advisory, and fitness for duty advisory on monthly retainer

August 1, 2026 · ~22 min read

A regional food processing company with 340 employees operates three facilities with OSHA-regulated exposures to lead in two battery cell assembly lines and noise above 85 dBA TWA in the packaging and processing departments. The company has a written OSHA medical surveillance program that specifies annual blood lead level testing for all battery assembly employees and baseline audiograms within six months of first noise exposure above 85 dBA TWA. In April, an OSHA compliance officer arrives for a general industry programmatic inspection. Within the first hour of document review, the inspector requests the medical surveillance records for all battery assembly employees and all noise-exposed employees hired since the previous inspection three years earlier.

The safety manager pulls the files. The blood lead records are complete — all twelve battery assembly employees have BLL results on file for the most recent year. But the inspector asks a second question: which employees had BLL results at or above 40 μg/dL in the past eighteen months, and were any of those employees provided with increased surveillance frequency in response? The safety manager reviews the records. Three employees had BLL results between 40 and 49 μg/dL over the prior eighteen months. None of them had been placed on increased surveillance frequency. Under 29 CFR 1910.1025(j)(2)(ii), employees whose BLL equals or exceeds 40 μg/dL must have their BLL monitored at least every two months, not annually. The annual surveillance had continued on its original schedule without the frequency adjustment triggered by the BLL result. OSHA issued a serious citation.

Between the last OSHA inspection three years earlier and the April inspection were the advisory hours that could have identified the BLL trigger issue before the inspector arrived: the quarterly medical surveillance schedule review that would have compared each employee’s BLL result against the 29 CFR 1910.1025(j) frequency trigger table; the audiometric program review that would have confirmed that all new-hire noise-exposed employees received baseline audiograms within six months of first exposure (not at the annual audiogram cycle); and the STS identification review that would have confirmed that standard threshold shifts in the annual audiogram cohort were being identified, documented, and referred for clinical follow-up before the OSHA recordability determination expired. Those hours are invisible in an occupational medicine advisory relationship that bills only for individual medical examination events, not for the ongoing program compliance monitoring that keeps the examination records admissible and the surveillance schedule compliant.

Occupational medicine consultants on monthly retainer — physicians board-certified in occupational and environmental medicine, and certified medical review officers who advise employers on OSHA medical surveillance programs, DOT drug and alcohol testing compliance, and fitness-for-duty evaluation — do a substantial share of their highest-value work between visible regulatory milestones. This guide covers OSHA medical surveillance advisory, DOT drug and alcohol testing advisory, and fitness-for-duty advisory: the regulatory frameworks behind each service area, the specific standards and trigger thresholds that govern the advisory, and how to structure a retainer agreement that makes the ongoing occupational medicine advisory work visible to the employer’s safety and HR teams between OSHA inspections and DOT audits.

OSHA medical surveillance advisory

OSHA medical surveillance advisory is the retainer function that evaluates the employer’s compliance with the mandatory medical surveillance requirements in OSHA’s chemical-specific health standards, identifying schedule and threshold trigger gaps before OSHA inspections, and advising on appropriate follow-up actions when surveillance results cross regulatory action levels or medical removal thresholds.

Lead medical surveillance: 29 CFR 1910.1025

The OSHA lead standard at 29 CFR 1910.1025 establishes one of the most detailed medical surveillance programs in OSHA’s health standards, with surveillance frequency, BLL trigger thresholds, medical removal protection obligations, and return-to-work criteria that create a layered compliance structure requiring active program management between annual surveillance cycles.

Initial medical surveillance under 29 CFR 1910.1025(j)(2)(i) applies to employees who are or may be exposed to lead at or above the action level (30 μg/m³ TWA) or for whom a physician determines the surveillance is necessary. Initial surveillance includes biological monitoring (blood lead level measurement, ZPP — zinc protoporphyrin), medical and work history, physical examination with emphasis on the central and peripheral nervous system, cardiovascular system, reproductive system, and kidney function, and a blood pressure measurement. Results of the initial BLL establish the baseline from which subsequent surveillance frequency and threshold triggers are applied.

Surveillance frequency is the most commonly mismanaged element of the lead surveillance program. The 29 CFR 1910.1025(j)(2)(ii) schedule requires: (A) at least every 6 months for employees for whom the last blood sampling and analysis indicated a BLL at or above 40 μg/dL — this is the standard surveillance interval for employees with elevated but sub-MRP BLL results; (B) at least every 2 months for employees whose last BLL indicated a level at or above 40 μg/dL AND who are currently experiencing levels above that threshold — specifically, employees whose BLL has been at or above 40 μg/dL three times in the most recent 18 months require monitoring at the 2-month frequency; and (C) at least every 6 months for employees whose exposure is at or above the action level without the specific BLL elevations described above. The transition from 6-month to 2-month monitoring frequency triggered by three BLL results at or above 40 μg/dL in 18 months is the element most frequently missed by employers who rely on an annual surveillance calendar rather than a BLL-result-triggered schedule.

Medical removal protection (MRP) under 29 CFR 1910.1025(j)(3) requires mandatory medical removal when an employee’s BLL equals or exceeds 60 μg/dL on a single test, or equals or exceeds 50 μg/dL on each of the two most recent tests performed at least two weeks apart. Upon medical removal, the employer must provide MRP benefits: the removed employee must receive the same earnings, seniority, and other rights and benefits that the employee would have had absent the MRP. MRP rate-retention applies for up to 18 months per removal occurrence. The retained occupational medicine consultant advising on MRP compliance evaluates whether the employer’s payroll and HR systems have a mechanism to implement the 18-month rate-retention obligation, whether the return-to-work criteria have been correctly communicated to the treating physician (two consecutive BLL results below 40 μg/dL, tested at least four weeks apart), and whether any current or recent removals are within the 18-month MRP window.

ZPP (zinc protoporphyrin) measurement is a secondary biological marker that lags behind BLL changes by four to six weeks (reflecting erythropoiesis over the RBC lifespan of approximately 120 days), making it useful for confirming chronic lead exposure but not for acute exposure assessment. The retained occupational medicine consultant advising on ZPP result interpretation evaluates the clinical significance of elevated ZPP in the context of each employee’s concurrent BLL: a BLL below 25 μg/dL with an elevated ZPP of 35 μg/dL or greater may indicate prior cumulative exposure not reflected in the current BLL, and may warrant clinical evaluation by the treating physician rather than a simple “below BLL trigger threshold” determination.

Respiratory protection medical evaluation: 29 CFR 1910.134

OSHA’s respiratory protection standard at 29 CFR 1910.134(e) requires that before an employee is required to use a respirator in the workplace, the employer must provide a medical evaluation to determine the employee’s ability to use a respirator. The medical evaluation must be performed by a physician or other licensed health care professional (PLHCP). The PLHCP must review the medical questionnaire completed by the employee (Appendix C to the standard, or an equivalent questionnaire), and must provide a written recommendation on whether the employee is medically able to use the respirator type required, with or without limitations.

The Appendix C questionnaire covers twelve required questions and five additional questions for employees using self-contained breathing apparatus (SCBA) or supplied-air respirators. The retained occupational medicine consultant reviewing an employer’s respiratory protection medical evaluation program evaluates several common compliance gaps: whether the questionnaire is being administered as a written questionnaire (not an oral screening), whether the employee is filling out the questionnaire during working hours or is being required to complete it on their own time (29 CFR 1910.134(e)(3) requires administration during normal working hours), and whether positive responses to the questionnaire are triggering a follow-up examination by the PLHCP or being filed without clinical follow-up.

Spirometry interpretation is the most technically demanding element of the respiratory protection medical evaluation when the employer requires negative-pressure air-purifying respirators (APRs) for employees with cardiopulmonary risk factors identified on the questionnaire. The retained occupational medicine consultant advising on spirometry interpretation evaluates whether the employer’s contracted occupational health clinic is applying ATS/ERS (American Thoracic Society/European Respiratory Society) acceptability criteria to the spirometry maneuvers — specifically, whether the FEV1 and FVC measurements meet the ATS/ERS 2019 criteria for maneuver quality (at least three acceptable maneuvers with a repeat FEV1 within 150 mL and repeat FVC within 150 mL) — and whether the PLHCP’s interpretation is using GLI-2012 reference equations (Global Lung Function Initiative) rather than older Knudson 1983 or NHANES III prediction equations that may underestimate obstruction in specific demographic groups. NIOSH-approved half-face and full-face air-purifying respirators require a minimum FEV1/FVC ratio of at least 0.70 (LLN per GLI-2012) and an FVC of at least 70% of predicted for routine clearance; employees with FEV1/FVC below 0.70 and FEV1 below 60% of predicted require clinical evaluation by the PLHCP before APR clearance.

Audiometric testing program: 29 CFR 1910.95

The OSHA occupational noise standard at 29 CFR 1910.95(g) requires audiometric testing for all employees whose noise exposures equal or exceed an eight-hour TWA of 85 dBA (the OSHA action level, measured on the A-scale with a 5 dB exchange rate). The audiometric testing program requires a baseline audiogram within six months of an employee’s first exposure at or above the action level (or within one year if a mobile test van is used), annual audiograms compared against the baseline, and the identification of standard threshold shifts (STS).

STS identification under 29 CFR 1910.95(g)(10) is a change in hearing threshold relative to the baseline audiogram of an average of 10 dB or more at 2000, 3000, and 4000 Hz in either ear. When an STS is identified in an annual audiogram, the employer is required to: notify the employee in writing within 21 days; fit the employee with hearing protectors (or refit if already wearing them) within 21 days if the employee is not already required to wear them; ensure that the employee is wearing appropriate hearing protection; and, if the audiologist, otolaryngologist, or physician evaluating the STS recommends referral, refer the employee for a clinical audiological evaluation. The retained occupational medicine consultant advising on the audiometric program evaluates whether the audiograms are being reviewed by an audiologist or physician and not simply filed, whether STS determinations are being made systematically (not left to the employee’s memory of their prior threshold values), and whether the 21-day notification and refitting obligation is being tracked with documented completion dates.

OSHA 300 log recordability of an STS is required under 29 CFR 1904.10 when the work-related STS results in a total hearing level of 25 dB or more above audiometric zero (averaged at 2000, 3000, and 4000 Hz) in the affected ear. The retained occupational medicine consultant evaluates whether the employer’s safety department is applying the correct test sequence: (1) determine whether an STS (10 dB average shift) occurred; (2) apply the age correction values from Appendix F to 29 CFR 1910.95 to determine whether the STS persists after age correction; (3) determine whether the post-age-correction STS results in a total hearing level of 25 dB or more above audiometric zero; and (4) if so, record the case on the OSHA 300 log as a hearing loss case. Employers who skip the age correction step frequently over-record audiometric cases as OSHA 300 recordable events, inflating their OSHA 300 log statistics. Employers who skip the total hearing level threshold check underrecord audiometric cases that should be entered on the log.

Case study: A food processing company with 280 noise-exposed employees in packaging and processing operations retained an occupational medicine consultant to review its audiometric testing program. The program had been administered for six years by the company’s occupational health clinic under a per-examination billing arrangement, with annual audiograms conducted for all employees on a fixed calendar schedule regardless of hire date. The consultant’s program review identified three compliance gaps. First, 22 employees hired in the preceding 14 months had not yet received baseline audiograms because the next annual audiogram cycle was eight months away — exceeding the six-month baseline requirement under 29 CFR 1910.95(g)(5)(ii) for employees with initial exposures above the action level. Second, 11 employees in the most recent annual cohort had STS results (10 dB average shift at 2000, 3000, 4000 Hz in at least one ear) but had not been notified in writing within the 21-day window. Third, the STS recordability determination had been applied incorrectly for six employees: the employer had recorded the STS directly on the OSHA 300 log without applying the age correction from Appendix F or checking the total hearing level threshold. After age correction, three of the six cases fell below the recordable threshold; two additional employees who had not been recorded had total hearing levels above 25 dB post-correction that should have been logged. The consultant issued a written advisory with a corrective action timeline: baseline audiograms for the 22 overdue employees within 30 days, retroactive written notification for the 11 STS employees (documenting the notification date even though beyond the 21-day window), and correction of the OSHA 300 log entries for the six misclassified cases.

DOT drug and alcohol testing advisory

DOT drug and alcohol testing advisory is the retainer function that evaluates the employer’s compliance with Department of Transportation drug and alcohol testing regulations under 49 CFR Part 40 and applicable modal regulations, advising on MRO verification procedures, program structure requirements, and the SAP referral and return-to-duty process.

49 CFR Part 40: MRO verification procedure advisory

49 CFR Part 40 (Procedures for Transportation Workplace Drug and Alcohol Testing Programs) establishes the uniform drug and alcohol testing procedures applicable to all DOT-regulated testing: FMCSA (49 CFR Part 382), FAA (14 CFR Part 120), FRA (49 CFR Part 219), FTA (49 CFR Part 655), PHMSA (49 CFR Part 199), and USCG (46 CFR Part 16). The MRO (Medical Review Officer) is the licensed physician who reviews all non-negative drug test results and makes the final determination whether the result is a verified positive, cancelled, or negative (with or without safety concern).

Positive result verification under 49 CFR 40.135 to 40.145 requires the MRO to contact the donor directly to determine whether there is a legitimate medical explanation for the positive result before the result is reported to the employer or DER (Designated Employer Representative). The MRO must interview the donor by telephone or in person, must allow the donor to present any medical documentation supporting a legitimate medical explanation, and must evaluate the clinical plausibility of the explanation in light of the specific drug or metabolite at the concentration reported. For example, a positive result for morphine at 2,000 ng/mL (above the MRO confirmation cutoff of 2,000 ng/mL per 49 CFR Part 40 Appendix D) with an explanation of prescribed codeine requires the MRO to evaluate whether the donor’s codeine prescription (with a stated dose and frequency) could clinically produce a morphine concentration at the measured level. The MRO cannot simply accept a prescription documentation without clinical plausibility evaluation.

Adulterated and substituted specimen determination under 49 CFR 40.91 and 40.93 follows a different pathway: the HHS-certified laboratory reports the adulteration finding (a pH below 3.0 or above 11.0, or presence of nitrite at or above 500 μg/mL, chromium (VI) at or above 50 μg/mL, or other adulterants listed in Subpart F) or substitution finding (creatinine below 2 mg/dL and specific gravity below 1.0010 or above 1.0200) on the custody and control form. The MRO contacts the donor and allows the donor to present a legitimate medical explanation. For substituted specimens, the only medical explanation that would result in a non-cancelled finding is a documented medical condition (such as nephrogenic diabetes insipidus) that physiologically produces a creatinine below 2 mg/dL in the donor’s normal, unmanipulated urine. The retained occupational medicine consultant advising MROs or employers with in-house MRO advisory needs evaluates the clinical plausibility of substitution explanations and the completeness of MRO documentation.

Shy bladder evaluation under 49 CFR 40.193 applies when a donor cannot provide a sufficient specimen volume (at least 45 mL for a urine specimen) within the collection time limit. The collector must document the shy bladder situation and direct the donor to drink up to 40 ounces of fluid over a three-hour period to attempt a second collection. If the donor still cannot provide a sufficient specimen, the MRO must evaluate whether the failure to provide a specimen is medically explained. The MRO refers the donor to a licensed physician with expertise in urology or another relevant specialty to evaluate whether a medical condition (such as a urological obstruction or renal condition) explains the inability to provide a specimen. The retained occupational medicine consultant advising on shy bladder evaluations ensures that the referral physician’s evaluation covers the clinical question that determines the outcome: can the donor’s documented medical condition explain the failure to provide a specimen without behavioral indicators of refusal?

FMCSA drug and alcohol testing: 49 CFR Part 382

FMCSA 49 CFR Part 382 requires drug and alcohol testing for commercial motor vehicle (CMV) drivers operating vehicles with a GVWR or combination weight of 26,001 pounds or more, vehicles designed to transport 16 or more passengers including the driver, or vehicles transporting hazardous materials requiring placarding. Testing categories include pre-employment (drug test required before first CMV operation, no alcohol test required), random (minimum annual testing rate: 50% of driver count for drugs, 10% for alcohol, as adjusted by FMCSA based on industry violation rates), post-accident (drug test required within 32 hours and alcohol test within 8 hours of an accident involving a fatality or a citation plus injury requiring immediate medical treatment or vehicle towing), reasonable suspicion (based on a trained supervisor’s observation of specific, contemporaneous, articulable physical and behavioral indicators of drug or alcohol use), and return-to-duty (a verified positive test result or refusal requires completion of a SAP evaluation and follow-up testing before the driver can return to safety-sensitive functions).

Random testing pool management is the most common source of FMCSA drug and alcohol testing violations for employers managing their own consortia or third-party administrator (TPA) relationships. The retained occupational medicine consultant advising on random pool compliance evaluates whether the employer’s random pool includes all Part 382-covered drivers (and excludes employees who are not CMV operators at the required GVWR threshold), whether the random selection process is truly random (using a scientifically valid method as required by 49 CFR 40.215), whether the minimum annual testing rate is being achieved (the number of tests conducted divided by the average number of drivers in the pool must equal or exceed the applicable annual rate), and whether selected drivers are being tested on a spread of dates throughout the year rather than all in the first quarter.

SAP referral and return-to-duty process

When a DOT drug test is verified positive, when an alcohol test result is 0.04 or greater, or when a driver refuses to test, the employer is prohibited from allowing the employee to perform any DOT safety-sensitive functions (driving, for FMCSA). The employee must be evaluated by a Substance Abuse Professional (SAP) — a licensed physician, psychologist, social worker, or addiction counselor certified by DOT-recognized professional certification boards — before any return to safety-sensitive duty. The SAP evaluates the employee, recommends a course of education or treatment, and conducts a follow-up evaluation after the employee has completed the recommended program. Only after the SAP provides a written determination that the employee has complied with the prescribed treatment can the employer conduct a return-to-duty test. The return-to-duty drug test must be a directly observed collection; the alcohol test must produce a result below 0.02.

The retained occupational medicine consultant advising on the SAP process evaluates whether the employer has a current list of SAP providers available to all covered employees, whether the employer is providing the required information to the employee about SAP evaluation resources without directing the employee to a specific SAP (the employer cannot specify the SAP), whether follow-up testing plans from completed SAP evaluations are being implemented (the minimum follow-up testing plan for drugs requires at least six tests in the first 12 months following return to duty, with testing possible for up to 60 months at the SAP’s discretion), and whether records of SAP evaluations, follow-up testing plans, and return-to-duty test results are being maintained in the driver qualification file or a separate confidential file as required by 49 CFR 382.401.

Fitness-for-duty advisory

Fitness-for-duty advisory is the retainer function that evaluates the employer’s protocols and practices for determining whether employees in safety-sensitive positions are physically and cognitively capable of performing their job duties without undue risk to themselves or others, including FMCSA commercial driver physical qualification under 49 CFR Part 391 and employer-developed fitness-for-duty evaluation protocols for non-DOT safety-sensitive positions.

FMCSA commercial driver physical qualification: 49 CFR Part 391

49 CFR Part 391 establishes the physical qualifications for commercial motor vehicle drivers, including vision, hearing, blood pressure, cardiovascular disease, respiratory disease, musculoskeletal conditions, neurological conditions (including epilepsy and loss of consciousness history), metabolic conditions (including diabetes mellitus), and history of substance use disorders. Drivers must be certified as physically qualified by a medical examiner listed on the FMCSA National Registry of Certified Medical Examiners (NRCME), and the medical examiner’s certificate (DOT physical) must be renewed at least every 24 months (or more frequently if the medical examiner determines based on the driver’s health status).

Vision standards under 49 CFR 391.41(b)(10) require distant acuity of at least 20/40 in each eye (with or without corrective lenses) using the Snellen chart, a field of vision of at least 70 degrees in the horizontal meridian in each eye, and the ability to recognize colors in a red, green, and amber traffic signal sequence. Drivers who cannot meet the vision standard in one eye may apply for a federal vision exemption through the FMCSA Vision Exemption Program, which requires a demonstrated safe driving history and is subject to annual renewal. The retained occupational medicine consultant advising employers with FMCSA-regulated drivers evaluates whether drivers with corrective lenses are carrying their corrective lenses during CDL examination and whether the vision standard is being applied to each eye individually rather than binocularly.

Blood pressure standards under 49 CFR 391.41(b)(6) provide a tiered certification framework based on the severity of hypertension. Stage 1 hypertension (systolic 140–159 mmHg or diastolic 90–99 mmHg) permits a one-year certificate with follow-up; Stage 2 hypertension (systolic 160–179 mmHg or diastolic 100–109 mmHg) permits a one-time three-month certificate to allow treatment and reassessment; Stage 3 hypertension (systolic 180 mmHg or greater or diastolic 110 mmHg or greater) disqualifies the driver until hypertension is treated and blood pressure falls below Stage 2 thresholds. Drivers certified on antihypertensive medication must be assessed for medication side effects (orthostatic hypotension, fatigue, drowsiness) that could impair driving performance. The retained consultant advising on blood pressure determinations evaluates whether the employer’s NRCME-certified examiners are applying the correct measurement protocol (seated position after five minutes of rest, correct cuff size for arm circumference) and whether the annual monitoring required for one-year Stage 1 certifications is being tracked and completed.

Diabetes mellitus presents the most complex fitness-for-duty determination in commercial driver qualification. Drivers treated with insulin have historically been disqualified from CMV operation in interstate commerce under 49 CFR 391.41(b)(3), which requires the driver to be free of any physical, mental, or organic disease or injury that interferes with the ability to control and safely operate a CMV. The FMCSA Federal Diabetes Exemption Program allows insulin-treated drivers who meet specified glycemic control criteria (HbA1c 10% or lower, no severe hypoglycemic episodes in the preceding 12 months, documentation of self-monitoring blood glucose) to apply for exemption and operate in interstate commerce with annual renewal and mandatory glucose monitoring protocols. The retained occupational medicine consultant advising employers with insulin-treated drivers evaluates whether affected drivers are enrolled in the exemption program, whether the annual renewal documentation is current, and whether the required glucose monitoring protocols (pre-trip, post-trip, and at two-hour intervals during long hauls) are being followed and documented.

Employer fitness-for-duty protocol development

For non-DOT safety-sensitive positions — power plant operators, crane operators, confined space workers, emergency responders, and other positions where impairment creates substantial injury risk — the retained occupational medicine consultant assists in developing fitness-for-duty evaluation protocols that define when a fitness-for-duty evaluation is required (following serious illness, injury, or medical event; upon reasonable suspicion of impairment; following extended absence from safety-sensitive duty), what the evaluation must include (medical history review, physical examination, functional capacity evaluation for specific job demands, drug screen), and how the attending physician’s return-to-work recommendation is evaluated by the employer.

The ADA interaction with fitness-for-duty evaluations is the most legally sensitive element of protocol design. Under 42 U.S.C. §12112(d)(4)(A), an employer may require a medical examination (after employment has begun) only if the examination is job-related and consistent with business necessity. For safety-sensitive positions, a fitness-for-duty examination following a medical event that raises a reasonable question about the employee’s ability to safely perform the job is generally consistent with the business necessity standard. The examination must be limited to the information needed to evaluate whether the employee can safely perform the essential functions of the safety-sensitive position with or without reasonable accommodation. The retained occupational medicine consultant advising on protocol design ensures that the fitness-for-duty examination scope is defined narrowly enough to satisfy ADA business necessity while broadly enough to address the genuine safety-relevant physical and cognitive demands of the position.

Case study: A transportation company with 185 CDL drivers retained an occupational medicine consultant to review its FMCSA medical surveillance and DOT drug and alcohol testing program after a DOT audit identified two compliance deficiencies: (1) two drivers were operating without current FMCSA medical examiner certificates (both drivers had certificates that had expired six weeks prior, and neither had been flagged in the employer’s driver qualification file management system); and (2) the company’s random drug testing rate for the prior calendar year was 46% of the driver pool — below the 50% FMCSA minimum annual rate required by 49 CFR 382.305(b)(1). DOT assessed a civil penalty of $14,750 for the two driver certificate violations and required the employer to demonstrate corrected compliance procedures within 90 days. The retained consultant’s program review identified three root causes. First, the driver qualification file management system used by the company’s safety department tracked certificate expiration dates but did not generate advance warning notifications; drivers were discovered expired only upon manual audit, not proactively before expiration. Second, the random testing pool had not been updated after the company reduced its driver count from 195 to 185 in the fourth quarter of the audit year; the testing rate was calculated against the 185-driver pool as of year-end, but the tests conducted (90 tests) reflected the 195-driver pool count from earlier in the year, producing an apparent rate of 46%. Third, the SAP follow-up testing files for two drivers who had completed return-to-duty programs in the prior 24 months contained no documentation confirming that the required minimum six follow-up tests in the first 12 months post-return had been conducted. The consultant issued a corrective action advisory: a 45-day advance expiration notification requirement for all FMCSA certificates, quarterly random pool count reconciliation to actual driver count, and SAP follow-up testing schedule tracking integrated into the driver qualification file management system.

Why occupational medicine consultant retainer hours are invisible between OSHA inspections and DOT audits

OSHA inspections and DOT audits are visible regulatory events with citation letters, abatement timelines, and civil penalty notices. What is invisible to the safety manager, HR director, or CFO are the advisory hours between those events: the quarterly BLL surveillance schedule review that identified three employees whose BLL results triggered the two-month frequency increase under 29 CFR 1910.1025(j)(2)(ii)(B) before the next OSHA inspection; the PLHCP questionnaire adequacy review that flagged a spirometry result requiring clinical evaluation before an employee with borderline FEV1/FVC was cleared for negative-pressure respirator use; the audiometric STS review that identified seven employees with standard threshold shifts requiring written notification and hearing protector refitting within the 21-day window; the DOT MRO file audit that identified shy bladder evaluations with incomplete physician evaluation documentation; and the FMCSA driver certificate tracking that generated 45-day advance notification of expiring certificates before drivers operated on expired credentials.

The invisibility problem in occupational medicine retainer relationships is structural: the highest-value advisory work occurs between the regulatory events that employers remember. A BLL surveillance schedule review that catches a two-month frequency trigger before the OSHA inspection produces a written schedule adjustment that is filed with the medical surveillance records. Its value — avoiding a 29 CFR 1910.1025(j)(2)(ii) citation — is only visible in retrospect when the OSHA inspector reviews the surveillance records and finds the frequency adjustment already made. An FMCSA certificate expiration tracking program that notifies the safety department 45 days before a driver’s certificate expires produces no visible regulatory event. Its value is the absence of an expired-certificate driving violation that would otherwise appear in the driver qualification file audit.

The billing problem is compounded by the regulatory complexity of occupational medicine deliverables. A BLL surveillance schedule advisory memo references specific 29 CFR 1910.1025 section numbers, individual employee BLL results, the specific trigger threshold crossed, and the required frequency change. An MRO file audit memo references specific 49 CFR Part 40 sections, specific CCF documentation deficiencies, and the non-cancellation rationale. An audiometric STS determination record references 29 CFR 1910.95(g)(10) STS criteria, the Appendix F age correction values applied, and the OSHA 300 log recordability determination. None of that technical work appears on an invoice as anything other than “occupational medicine advisory — 5 hours” without a structured work log that captures which program was reviewed, which regulatory standard was applied, what trigger threshold was evaluated, and what advisory was issued.

HourTab is a retainer hours dashboard designed for advisory relationships like occupational medicine consulting retainers where client value is created between the visible milestones of OSHA inspections and DOT audits. The retained occupational medicine consultant logs hours against specific tasks — BLL surveillance schedule review for a specific employee group, PLHCP questionnaire adequacy review, audiometric STS determination for the annual cohort, MRO file audit, FMCSA certificate expiration tracking — with technical notes identifying the regulatory standard applied, the specific finding, and the advisory direction. The consultant shares a public URL that gives the safety manager a running view of hours balance and work log between inspection cycles and DOT audits, without requiring a client login or portal account. The quarterly BLL surveillance review that caught the two-month frequency trigger becomes a work log entry: the employee group, the BLL result that crossed the threshold, the 29 CFR 1910.1025(j)(2)(ii)(B) trigger rule applied, and the updated surveillance schedule issued. The advisory hour is no longer invisible.

Setting up an occupational medicine consultant retainer agreement

An occupational medicine consultant retainer agreement should define the scope with enough specificity to distinguish routine advisory tasks included in the monthly retainer — OSHA medical surveillance schedule review, PLHCP adequacy advisory, audiometric STS identification, DOT MRO file compliance advisory, FMCSA certificate tracking — from activities that require separate scoping: individual employee medical examinations (including DOT physicals conducted as the NRCME-listed examiner), actual MRO verification of specific test results (individual test review is typically billed per-test rather than under the advisory retainer), fitness-for-duty examinations requiring in-person evaluation, and expert testimony for OSHA enforcement defense or DOT administrative proceedings.

A well-structured occupational medicine consultant retainer specifies:

Services covered: OSHA medical surveillance program advisory for specified regulated substances (lead, hexavalent chromium, cadmium, asbestos, noise, and others as applicable); respiratory protection PLHCP questionnaire and spirometry adequacy advisory; audiometric STS identification, notification tracking, and OSHA 300 log recordability determination; DOT drug and alcohol testing program compliance advisory (pool management, MRO file completeness review, SAP referral and follow-up testing tracking); FMCSA commercial driver physical qualification certificate tracking and physical qualification standard advisory; and fitness-for-duty protocol development for safety-sensitive positions.

Applicable regulations and standards: 29 CFR 1910.1025 (lead), 29 CFR 1910.1026 (hexavalent chromium), 29 CFR 1910.1001 (asbestos), 29 CFR 1910.134 (respiratory protection), 29 CFR 1910.95 (occupational noise), 29 CFR 1904.10 (recording criteria for cases involving occupational hearing loss), 49 CFR Part 40 (DOT drug and alcohol testing procedures), 49 CFR Part 382 (FMCSA drug and alcohol testing), 49 CFR Part 391 (FMCSA driver qualification), ATS/ERS 2019 spirometry acceptability criteria, GLI-2012 spirometry reference equations, ACGIH BEI framework for ZPP interpretation, AAMRO and MROCC MRO certification standards, and applicable ADA 42 U.S.C. §12112(d) provisions for medical examination scope.

Deliverables: quarterly BLL surveillance schedule review memo (BLL result table by employee, trigger threshold analysis, frequency adjustment recommendations); annual respiratory protection PLHCP adequacy review memo (questionnaire completeness evaluation, spirometry interpretation adequacy, follow-up examination recommendations); annual audiometric program review memo (STS determination table, age-correction calculation, 21-day notification tracking, OSHA 300 log recordability determination); annual DOT compliance advisory memo (random pool count reconciliation, testing rate calculation, MRO file completeness review, SAP follow-up testing verification); quarterly FMCSA certificate expiration tracking report; and fitness-for-duty evaluation protocol (written protocol defining triggering events, examination scope, ADA business necessity rationale, and return-to-work recommendation criteria).

Rates: Occupational health nurses and physician assistants with specialty occupational health training — primarily conducting surveillance record review, STS tracking, and DOT testing program administrative advisory — typically bill at $85 to $140 per hour. Physicians board-certified in occupational and environmental medicine providing direct OSHA surveillance advisory, PLHCP services, and fitness-for-duty protocol development typically bill at $175 to $275 per hour. Certified Medical Review Officers providing DOT testing program advisory (not individual test review) typically bill at $150 to $250 per hour for program advisory work.

Monthly retainer: $2,500 to $8,000 per month depending on the number of employees under OSHA medical surveillance, the number of DOT-regulated employees requiring MRO advisory, and whether the retainer covers FMCSA driver qualification tracking, actual PLHCP services, and fitness-for-duty protocol development or only program compliance advisory. An employer with 50 noise-exposed employees and no DOT-regulated drivers may structure a $2,500 to $3,500 monthly retainer covering audiometric STS review, PLHCP advisory for the respirator program, and OSHA medical surveillance schedule maintenance. A multi-facility employer with 300 noise- and lead-exposed employees, 120 CDL drivers requiring DOT testing program oversight, and a fitness-for-duty protocol for crane operators will typically structure a $5,000 to $8,000 monthly retainer covering all three service areas with quarterly deliverables.

HourTab turns a time-tracker CSV into a public retainer-hours URL your client can bookmark. No client login. No portal setup. Start free →